Last 12 months
Inside the activity.
0 purchase rows · 24 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2020 Filed Jan 8, 2020 23:04 UTC |
DAVIS STEPHENDirector · CEO
|
GrantRestricted Stock Units · Derivative | 38,110 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-002597 · doc4.xml · derivative · entry 2 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,110 Underlying: Common Stock · 38,110 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 6, 2021. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 6, 2021. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 23:04 UTC |
DAVIS STEPHENDirector · CEO
|
GrantStock Options (Right to Buy) · Derivative | 138,304 | $0.00 Strike: $42.81 | $0.00 |
DisclosureSEC source: 0001209191-20-002597 · doc4.xml · derivative · entry 1 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,304 Underlying: Common Stock · 138,304 shares Expires 2030-01-06 F1 · derivative.exercise_date: 25% of the shares subject to the Stock Option will vest and become exercisable on January 6, 2021. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 22:35 UTC |
YANG MICHAEL J.EVP and CCO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 72,979 | $0.00 Strike: $35.86 | $0.00 |
DisclosureSEC source: 0001209191-19-060476 · doc4.xml · derivative · entry 8 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,500 Underlying: Common Stock · 72,979 shares Expires 2027-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 25% of the 400,000 shares originally subject to the stock option vested and became exercisable on March 29, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 22:35 UTC |
YANG MICHAEL J.EVP and CCO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $21.28 | $0.00 |
DisclosureSEC source: 0001209191-19-060476 · doc4.xml · derivative · entry 7 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 10,000 shares Expires 2028-10-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 25% of the 40,000 shares originally subject to the Stock Option vested and became exercisable on October 15, 2019. The remaining shares vest and become excercisable thereafter in 36 equal monthly installments. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 22:35 UTC |
YANG MICHAEL J.EVP and CCO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $19.98 | $0.00 |
DisclosureSEC source: 0001209191-19-060476 · doc4.xml · derivative · entry 6 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 577,500 Underlying: Common Stock · 22,500 shares Expires 2028-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the 600,000 shares originally subject to the Stock Option vested and became exercisable on April 18, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 22:35 UTC |
YANG MICHAEL J.EVP and CCO
|
SaleCommon Stock | 5,032 | $43.74 | $220,074.52 |
DisclosureSEC source: 0001209191-19-060476 · doc4.xml · nonDerivative · entry 5 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,499 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.67 to $43.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 22:35 UTC |
YANG MICHAEL J.EVP and CCO
|
SaleCommon Stock | 100,447 | $44.49 | $4,469,188.37 |
DisclosureSEC source: 0001209191-19-060476 · doc4.xml · nonDerivative · entry 4 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,531 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.755 to $44.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 22:35 UTC |
YANG MICHAEL J.EVP and CCO
|
Exercise / conversionCommon Stock | 72,979 | $35.86 | $2,617,026.94 |
DisclosureSEC source: 0001209191-19-060476 · doc4.xml · nonDerivative · entry 3 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,978 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 22:35 UTC |
YANG MICHAEL J.EVP and CCO
|
Exercise / conversionCommon Stock | 10,000 | $21.28 | $212,800.00 |
DisclosureSEC source: 0001209191-19-060476 · doc4.xml · nonDerivative · entry 2 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 22:35 UTC |
YANG MICHAEL J.EVP and CCO
|
Exercise / conversionCommon Stock | 22,500 | $19.98 | $449,550.00 |
DisclosureSEC source: 0001209191-19-060476 · doc4.xml · nonDerivative · entry 1 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 876 shares of the Issuer's common stock acquired by the reporting person on November 15, 2017 pursuant to an employee stock purchase program. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 22:34 UTC |
KIM AUSTIN D.EVP & General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $17.58 | $0.00 |
DisclosureSEC source: 0001209191-19-060475 · doc4.xml · derivative · entry 3 KIM AUSTIN D. · CIK 0001746240 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,500 Underlying: Common Stock · 17,500 shares Expires 2028-07-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the 140,000 shares originally subject to the stock option vested and became exercisable on July 18, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 22:34 UTC |
KIM AUSTIN D.EVP & General Counsel
|
SaleCommon Stock | 17,500 | $45.06 | $788,576.25 |
DisclosureSEC source: 0001209191-19-060475 · doc4.xml · nonDerivative · entry 2 KIM AUSTIN D. · CIK 0001746240 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 509 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.215, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 22:34 UTC |
KIM AUSTIN D.EVP & General Counsel
|
Exercise / conversionCommon Stock | 17,500 | $17.58 | $307,650.00 |
DisclosureSEC source: 0001209191-19-060475 · doc4.xml · nonDerivative · entry 1 KIM AUSTIN D. · CIK 0001746240 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 452 shares of the Issuer's common stock acquired by the reporting person on May 15, 2019 and 57 shares of the Issuer's common stock acquired by the reporting person on November 15, 2019 pursuant to an employee stock purchase program. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 23:30 UTC |
YANG MICHAEL J.EVP and CCO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,521 | $0.00 Strike: $35.86 | $0.00 |
DisclosureSEC source: 0001209191-19-060101 · doc4.xml · derivative · entry 4 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385,479 Underlying: Common Stock · 14,521 shares Expires 2027-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 400,000 shares originally subject to the stock option vested and became exercisable on March 29, 2018. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 23:30 UTC |
YANG MICHAEL J.EVP and CCO
|
SaleCommon Stock | 3,502 | $50.05 | $175,285.96 |
DisclosureSEC source: 0001209191-19-060101 · doc4.xml · nonDerivative · entry 3 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,623 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 23:30 UTC |
YANG MICHAEL J.EVP and CCO
|
SaleCommon Stock | 11,019 | $50.60 | $557,506.31 |
DisclosureSEC source: 0001209191-19-060101 · doc4.xml · nonDerivative · entry 2 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,125 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.17 to $51.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 23:30 UTC |
YANG MICHAEL J.EVP and CCO
|
Exercise / conversionCommon Stock | 14,521 | $35.86 | $520,723.06 |
DisclosureSEC source: 0001209191-19-060101 · doc4.xml · nonDerivative · entry 1 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 23:29 UTC |
Ridloff ElenaEVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 36,000 | $0.00 Strike: $15.81 | $0.00 |
DisclosureSEC source: 0001209191-19-060100 · doc4.xml · derivative · entry 5 Ridloff Elena · CIK 0001772518 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,000 Underlying: Common Stock · 36,000 shares Expires 2028-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the 100,000 shares originally subject to the stock option vested and became exercisable on April 30, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 23:29 UTC |
Ridloff ElenaEVP and CFO
|
SaleCommon Stock | 19,478 | $49.09 | $956,252.93 |
DisclosureSEC source: 0001209191-19-060100 · doc4.xml · nonDerivative · entry 4 Ridloff Elena · CIK 0001772518 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.75 to $49.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 23:29 UTC |
Ridloff ElenaEVP and CFO
|
SaleCommon Stock | 5,502 | $49.81 | $274,043.62 |
DisclosureSEC source: 0001209191-19-060100 · doc4.xml · nonDerivative · entry 3 Ridloff Elena · CIK 0001772518 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,478 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.19 to $50.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 23:29 UTC |
Ridloff ElenaEVP and CFO
|
SaleCommon Stock | 11,020 | $50.60 | $557,556.90 |
DisclosureSEC source: 0001209191-19-060100 · doc4.xml · nonDerivative · entry 2 Ridloff Elena · CIK 0001772518 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,980 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.17 to $51.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 09, 2019 Filed Dec 11, 2019 23:29 UTC |
Ridloff ElenaEVP and CFO
|
Exercise / conversionCommon Stock | 36,000 | $15.81 | $569,160.00 |
DisclosureSEC source: 0001209191-19-060100 · doc4.xml · nonDerivative · entry 1 Ridloff Elena · CIK 0001772518 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 23:25 UTC |
DAVIS STEPHENDirector · CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $19.65 | $0.00 |
DisclosureSEC source: 0001209191-19-059526 · doc4.xml · derivative · entry 5 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 150,000 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the 600,000 shares originally subject to the stock option vested and became exercisable on March 15, 2017, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 23:25 UTC |
DAVIS STEPHENDirector · CEO
|
SaleCommon Stock | 28,256 | $51.32 | $1,450,097.92 |
DisclosureSEC source: 0001209191-19-059526 · doc4.xml · nonDerivative · entry 4 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,954 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 22, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.72 to $51.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 23:25 UTC |
DAVIS STEPHENDirector · CEO
|
SaleCommon Stock | 40,159 | $52.09 | $2,091,882.31 |
DisclosureSEC source: 0001209191-19-059526 · doc4.xml · nonDerivative · entry 3 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,210 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 22, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.63 to $52.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 23:25 UTC |
DAVIS STEPHENDirector · CEO
|
SaleCommon Stock | 81,585 | $52.82 | $4,309,319.70 |
DisclosureSEC source: 0001209191-19-059526 · doc4.xml · nonDerivative · entry 2 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,369 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 22, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.64 to $53.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| December 05, 2019 Filed Dec 6, 2019 23:25 UTC |
DAVIS STEPHENDirector · CEO
|
Exercise / conversionCommon Stock | 150,000 | $19.65 | $2,947,500.00 |
DisclosureSEC source: 0001209191-19-059526 · doc4.xml · nonDerivative · entry 1 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,954 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 22:37 UTC |
Stankovic Srdjan R.President
|
Exercise / conversionRestricted Stock Units · Derivative | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-057636 · doc4.xml · derivative · entry 3 Stankovic Srdjan R. · CIK 0001432545 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 6,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning 11/19/2019. F4 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning 11/19/2019. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 22:37 UTC |
Stankovic Srdjan R.President
|
SaleCommon Stock | 2,160 | $46.41 | $100,245.60 |
DisclosureSEC source: 0001209191-19-057636 · doc4.xml · nonDerivative · entry 2 Stankovic Srdjan R. · CIK 0001432545 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,027 F2 · kind: The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. F3 · price: The reported price in Column 4 is a weighted average price, and includes 2,153 shares sold at $46.41 and 7 shares sold at $46.7644. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 22:37 UTC |
Stankovic Srdjan R.President
|
Exercise / conversionCommon Stock | 6,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-057636 · doc4.xml · nonDerivative · entry 1 Stankovic Srdjan R. · CIK 0001432545 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:23 UTC |
DAVIS STEPHENDirector · CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 5,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-053491 · doc4.xml · derivative · entry 3 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,813 Underlying: Common Stock · 5,937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning 10/15/19. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning 10/15/19. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:23 UTC |
DAVIS STEPHENDirector · CEO
|
SaleCommon Stock | 2,983 | $39.65 | $118,275.95 |
DisclosureSEC source: 0001209191-19-053491 · doc4.xml · nonDerivative · entry 2 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,954 F2 · kind: The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:23 UTC |
DAVIS STEPHENDirector · CEO
|
Exercise / conversionCommon Stock | 5,937 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-053491 · doc4.xml · nonDerivative · entry 1 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:26 UTC |
Miller Eric AlejandroController & PAO
|
Exercise / conversionRestricted Stock Units · Derivative | 417 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-053494 · doc4.xml · derivative · entry 3 Miller Eric Alejandro · CIK 0001758494 · Controller & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,254 Underlying: Common Stock · 417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning 10/15/19. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning 10/15/19. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:26 UTC |
Miller Eric AlejandroController & PAO
|
SaleCommon Stock | 147 | $39.65 | $5,828.55 |
DisclosureSEC source: 0001209191-19-053494 · doc4.xml · nonDerivative · entry 2 Miller Eric Alejandro · CIK 0001758494 · Controller & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270 F2 · kind: The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:26 UTC |
Miller Eric AlejandroController & PAO
|
Exercise / conversionCommon Stock | 417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-053494 · doc4.xml · nonDerivative · entry 1 Miller Eric Alejandro · CIK 0001758494 · Controller & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:25 UTC |
YANG MICHAEL J.EVP and CCO
|
Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-053493 · doc4.xml · derivative · entry 3 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning 10/15/19. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning 10/15/19. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:25 UTC |
YANG MICHAEL J.EVP and CCO
|
SaleCommon Stock | 877 | $39.65 | $34,773.05 |
DisclosureSEC source: 0001209191-19-053493 · doc4.xml · nonDerivative · entry 2 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,623 F2 · kind: The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:25 UTC |
YANG MICHAEL J.EVP and CCO
|
Exercise / conversionCommon Stock | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-053493 · doc4.xml · nonDerivative · entry 1 YANG MICHAEL J. · CIK 0001702283 · EVP and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:24 UTC |
Stankovic Srdjan R.President
|
Exercise / conversionRestricted Stock Units · Derivative | 2,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-053492 · doc4.xml · derivative · entry 3 Stankovic Srdjan R. · CIK 0001432545 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,907 Underlying: Common Stock · 2,968 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning 10/15/19. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning 10/15/19. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:24 UTC |
Stankovic Srdjan R.President
|
SaleCommon Stock | 1,031 | $39.65 | $40,879.15 |
DisclosureSEC source: 0001209191-19-053492 · doc4.xml · nonDerivative · entry 2 Stankovic Srdjan R. · CIK 0001432545 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,937 F2 · kind: The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:24 UTC |
Stankovic Srdjan R.President
|
Exercise / conversionCommon Stock | 2,968 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-053492 · doc4.xml · nonDerivative · entry 1 Stankovic Srdjan R. · CIK 0001432545 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 10, 2019 Filed Oct 11, 2019 21:39 UTC |
DAVIS STEPHENDirector · CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 120,208 | $0.00 Strike: $19.65 | $0.00 |
DisclosureSEC source: 0001209191-19-053060 · doc4.xml · derivative · entry 6 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 120,208 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 600,000 shares subject to the stock option vested and became exercisable on March 15, 2017, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 10, 2019 Filed Oct 11, 2019 21:39 UTC |
DAVIS STEPHENDirector · CEO
|
SaleCommon Stock | 120,208 | $40.19 | $4,831,039.31 |
DisclosureSEC source: 0001209191-19-053060 · doc4.xml · nonDerivative · entry 4 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 22, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| October 10, 2019 Filed Oct 11, 2019 21:39 UTC |
DAVIS STEPHENDirector · CEO
|
Exercise / conversionCommon Stock | 120,208 | $19.65 | $2,362,087.20 |
DisclosureSEC source: 0001209191-19-053060 · doc4.xml · nonDerivative · entry 3 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2019 Filed Oct 11, 2019 21:39 UTC |
DAVIS STEPHENDirector · CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 29,792 | $0.00 Strike: $19.65 | $0.00 |
DisclosureSEC source: 0001209191-19-053060 · doc4.xml · derivative · entry 5 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,208 Underlying: Common Stock · 29,792 shares Expires 2026-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the 600,000 shares subject to the stock option vested and became exercisable on March 15, 2017, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 09, 2019 Filed Oct 11, 2019 21:39 UTC |
DAVIS STEPHENDirector · CEO
|
SaleCommon Stock | 29,792 | $40.00 | $1,191,709.79 |
DisclosureSEC source: 0001209191-19-053060 · doc4.xml · nonDerivative · entry 2 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 22, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.225, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| October 09, 2019 Filed Oct 11, 2019 21:39 UTC |
DAVIS STEPHENDirector · CEO
|
Exercise / conversionCommon Stock | 29,792 | $19.65 | $585,412.80 |
DisclosureSEC source: 0001209191-19-053060 · doc4.xml · nonDerivative · entry 1 DAVIS STEPHEN · CIK 0001131146 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2019 Filed Sep 20, 2019 20:28 UTC |
BAKER BROS. ADVISORS LPDirector · 10% owner
667, L.P.Director · 10% owner
Baker Bros. Advisors (GP) LLCDirector · 10% owner
Baker Brothers Life Sciences LPDirector · 10% owner
BAKER FELIXDirector · 10% owner
BAKER JULIANDirector · 10% owner
|
PurchaseCommon Stock | 1,494,025 | $40.00 | $59,761,000.00 |
DisclosureSEC source: 0001638599-19-000877 · doc4_6305.xml · nonDerivative · entry 4 BAKER BROS. ADVISORS LP · CIK 0001263508 · Director · 10% owner 667, L.P. · CIK 0001551139 · Director · 10% owner Baker Bros. Advisors (GP) LLC · CIK 0001580575 · Director · 10% owner Baker Brothers Life Sciences LP · CIK 0001363364 · Director · 10% owner BAKER FELIX · CIK 0001087940 · Director · 10% owner BAKER JULIAN · CIK 0001087939 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 37,470,965 F3 · ownership.nature: 667, L.P. ("667") and Baker Brothers Life Sciences, L.P. ("Life Sciences", and together with 667, the "Funds") purchased 68,475 and 1,494,025 shares of Common Stock, respectively, for $40.00 per share in an underwritten public offering (the "Offering") that closed on September 20, 2019. F5 · ownership.nature: After giving effect to the transaction reported herein and as a result of their ownership interest in (i) Baker Brothers Life Sciences Capital, L.P. and (ii) Life Sciences, Julian C. Baker and Felix J. Baker each may be deemed to have an indirect pecuniary interest in Common Stock of the Issuer reported in column 5 of Table I directly held by Life Sciences, a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital, L.P., a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital (GP), LLC, due to their interest in Life Sciences and Baker Brothers Life Sciences Capital, L.P.'s right to receive an allocation of a portion of the profits from Life Sciences. F6 · ownership.nature: Baker Bros. Advisors LP (the "Adviser") serves as the investment adviser to the Funds. In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held by the Funds. Baker Bros. Advisors (GP) LLC (the "Adviser GP") is the Adviser's sole general partner. Julian C. Baker and Felix J. Baker are managing members of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held by the Funds. The general partners of the Funds relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held by the Funds. F7 · ownership.nature: Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is a beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document |
| September 20, 2019 Filed Sep 20, 2019 20:28 UTC |
BAKER BROS. ADVISORS LPDirector · 10% owner
667, L.P.Director · 10% owner
Baker Bros. Advisors (GP) LLCDirector · 10% owner
Baker Brothers Life Sciences LPDirector · 10% owner
BAKER FELIXDirector · 10% owner
BAKER JULIANDirector · 10% owner
|
PurchaseCommon Stock | 68,475 | $40.00 | $2,739,000.00 |
DisclosureSEC source: 0001638599-19-000877 · doc4_6305.xml · nonDerivative · entry 3 BAKER BROS. ADVISORS LP · CIK 0001263508 · Director · 10% owner 667, L.P. · CIK 0001551139 · Director · 10% owner Baker Bros. Advisors (GP) LLC · CIK 0001580575 · Director · 10% owner Baker Brothers Life Sciences LP · CIK 0001363364 · Director · 10% owner BAKER FELIX · CIK 0001087940 · Director · 10% owner BAKER JULIAN · CIK 0001087939 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,383,621 F3 · ownership.nature: 667, L.P. ("667") and Baker Brothers Life Sciences, L.P. ("Life Sciences", and together with 667, the "Funds") purchased 68,475 and 1,494,025 shares of Common Stock, respectively, for $40.00 per share in an underwritten public offering (the "Offering") that closed on September 20, 2019. F4 · ownership.nature: After giving effect to the transaction reported herein and as a result of their ownership interest in (i) Baker Biotech Capital, L.P. and (ii) 667, Julian C. Baker and Felix J. Baker each may be deemed to have an indirect pecuniary interest in Common Stock reported in column 5 of Table I directly held by 667, a limited partnership of which the sole general partner is Baker Biotech Capital, L.P., a limited partnership of which the sole general partner is Baker Biotech Capital (GP), LLC, due to their interest in 667 and Baker Biotech Capital, L.P.'s right to receive an allocation of a portion of the profits from 667. F6 · ownership.nature: Baker Bros. Advisors LP (the "Adviser") serves as the investment adviser to the Funds. In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held by the Funds. Baker Bros. Advisors (GP) LLC (the "Adviser GP") is the Adviser's sole general partner. Julian C. Baker and Felix J. Baker are managing members of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held by the Funds. The general partners of the Funds relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held by the Funds. F7 · ownership.nature: Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is a beneficial owner of such securities for purposes of Section 16 or any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.